参考文献/References:
[1] Wu H,Bui MM,Leston DG,et al.Clinical characteristics and prognostic factors of bone lymphomas:focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas[J].BMC Cancer,2014,14:900.
[2] Zhang LJ,Lin QD,Zhang L,et al.Primary skeletal muscle diffuse large B cell lymphoma:a case report and review of the literature[J].Oncology Letters,2015(10):2156-2160.
[3] 白人驹.医学影像诊断学[M].北京:人民卫生出版社,2010:720.
[4] Sehn LH,Hardy ELG,Gill KK,et al. Phase 2 trial of interim PET scan-tailored therapy in patients with advanced stage diffuse large B-cell lymphoma(DLBCL)in British Columbia(BC)[J]. Blood(ASH Annual Meeting Abstracts),2014,124:392.
[5] Tilly H,Gomes da Silva M,Vitolo UA,et al.Diffuse large B-cell lymphoma(DLBCL):ESMO clinical practice guidelines for diagnasis,treatment and follow-up[J].Ann Oncology,2015,26(S5):116-125.
[6] Beal K,Allen L,Yahalom J. Primary bone lymphoma:treatment results and prognostic factors with long-term follow-up of 82 patients[J].Cancer,2006,106(12):2652-2656.
[7] 旷仁钊,唐晓平,张涛,等.顶枕部颅骨弥漫性大 B 细胞淋巴瘤 1 例[J].中华神经外科疾病研究杂志,2015,14(1):85-86.
[8] Deans JP,Li H,Polyak MJ.CD20-mediated apoptosis:signalling through lipidrafts[J].J Immunology,2002,107(2):176-182.
[9] Knowles B,Serpell JW.Extra-nodal lymphoma presenting as a mimic of soft-tissue sarcoma[J]. ANZ J Surg,2003,73(1-2):26-30.
[10] 苏孟,王文岭,田艳丽,等.弥漫性大B淋巴细胞瘤(腿型)1例[J].临床皮肤科杂志,2015,44(6):386-387.
[11] Tong MY,Zhang X,Yu Z,et al.Primary sternum diffuse large B-cell lymphoma:a case report and review of the literature[J].Leuk Lymphoma,2010,51:1-2.
[12] 张迪.骨原发性淋巴瘤9例临床诊治分析[D].济南:山东大学,2011.
[13] 许尚文,成官迅,陈自谦.骨原发性淋巴瘤的MRI 表现[J].中国临床医学影像杂志,2006,17(3):161-163.
[14] Hishizawa M,Okamoto K,Chonabayashi K,et al. Primary large B-cell lymphoma of the bone marrow[J]. Br J Haematol,2007,136(3):351.
[15] Dorth JA,Prosnitz LR,Broadwater G,et al.Radiotherapy dose-response analysis for diffuse large B-cell lymphoma with a complete response to chemo-therapy[J]. Radiat Oncol,2012,7(1):100.
[16] 李庆,李里香.弥漫性大B细胞淋巴瘤的研究进展[J].江西医学院学报,2009,49(11):117-120.
[17] 李陶,周立强.弥漫性大B细胞淋巴瘤诊治进展[J].癌症进展杂志,2006,9(5):384-390.
[18] Kong SY,Cho EH,Woo HY,et al. Denovo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean[J]. J Korean Med Sci,2004,19(6):815-819.
[19] Kajiura D,Yamashita Y,Mori N. Diffuse large B-cell lymphoma initially manifesting in the bone marrow[J]. Am J Clin Pathol,2007,127(5):762-769.
[20] 张赟.骨髓炎与恶性骨肿瘤软组织改变的影像学对比研究[D].青岛:青岛大学,2014.
[21] Mondello P,Mian M,Arrigo C,et al.Primary diffuse large B-cell lymphoma of the bone:bendamustine and rituximab are able to overcome resistant disease[J].Springer Plus,2014(3):342.
[22] Mikhaeel NG. Primary bone lymphoma[J].Clin Oncol(R Coll Radiol),2012,24(5):366-370.
[23] Jung YK,Woo S,Han CW.Clinical characteristics and outcomes in diffuse large B cell lymphoma patients aged 70 years and older:a single-center experience with a literature review[J].Korean J Intern Med,2015,30(5):684-693.
[24] Coiffier B,Thieblemont C,Van Den Neste E,et al.Long-term outcome of patients in the LNH-98.5 trial,the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients:a study by the Groupe d'Etudes des Lymphomes de l'Adulte[J]. Blood,2010,116(12):2040-2045.
[25] Kazama H,Teramura M,Yoshinaga K,et al.Long-term remission of primary bone marrow diffuse large B-cell lymphoma treated with high-dose chemotherapy rescued by in vivo rituximab-purged autologous stem cells[J]. Case Rep Med,2012:957063.
[26] Hu Y,Chen SL,Huang ZX,et al. An diffuse large B-cell lymphoma in the primary bone marrow[J].Genetics and Molecular Research,2015,14(2):6247-6250.
[27] 杨渤彦,勇威本,朱军,等.弥漫性大B细胞淋巴瘤的临床特征及预后影响因素分析[J].中华肿瘤杂志,2005,27(3):174-176.
[28] The International Non-Hodgkin's Lymphoma Prognostic Factor Project.A predictive model for aggressive non-Hodgkin's lymphoma[J].N Engl J Med,1993,229(14):987-994.
[29] Blay J,Gomez F,Sebban C,et al.The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse:analysis of the PARMA trial,Parma Group[J].Blood,1998,92(10):3562-3568.
[30] Reddy N,Greer JP.Primary bone lymphoma:a set of unique problems in management[J].Leuk Lymphoma,2010,51(1):1-2.